
Pepciltaz 4.5 Injection
Marketer
Liza Life Sciences
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Pepciltaz 4.5 Injection
Combiflox 4.5 Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by a healthcare provider, the dosage and frequency are tailored by your physician to your specific condition. Strict adherence to the prescribed regimen is crucial. Potential side effects encompass nausea, vomiting, diarrhea, and skin rashes, along with possible injection site reactions such as pain, swelling, or redness. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver impairments to your doctor, who may adjust the dosage or recommend an alternative. Under medical guidance, this injection is generally deemed safe for pregnant and breastfeeding individuals.
Uses of Pepciltaz 4.5 Injection
Infections caused by bacteria
Major Benefits of Pepciltaz 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Pepciltaz 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Pepciltaz 4.5 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Pepciltaz 4.5 Injection works:
Pepciltaz 4.5 Injection unites Piperacillin, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum augments Piperacillin's effectiveness by neutralizing enzymes that would otherwise render it inactive, thus broadening its antibacterial spectrum.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Pepciltaz 4.5 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Pepciltaz 4.5 is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; however, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation is compatible with the administration of Pepciltaz 4.5 Injection. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pepciltaz 4.5 Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should use Pepciltaz 4.5 Injection cautiously. The prescribed dose of Pepciltaz 4.5 Injection may require modification. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Pepciltaz 4.5 Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dosage modification might not be necessary for this patient population. However, physician consultation is advised.
What if you forget to take Pepciltaz 4.5 Injection :
Omit a Pepciltaz 4.5 Injection dose? Seek medical advice immediately.
Facts to Know About Pepciltaz 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
